Skip to main content

Coronavirus (COVID-19): Visitor Restrictions, Resources, and Updates

Explore URMC
menu
Wilmot Cancer Research Fellowship Supports ‘Trajectory of Learning’

Wilmot Cancer Research Fellowship Supports ‘Trajectory of Learning’

Wilmot’s support for education continues beyond formal medical and scientific training to professional development for faculty and staff. A special mechanism is devoted to this kind of ongoing training: the Wilmot Cancer Research Fellowship is for physicians who have completed their post-graduate training and are on the cusp of their research careers.

Does Chemo Brain Go Away? Wilmot Scientists Investigate

Does Chemo Brain Go Away? Wilmot Scientists Investigate

Wilmot Cancer Institute scientists have already discovered that “chemo brain” is a substantial problem that can linger for six months after chemotherapy ends. A new, $3 million grant ensures the research will continue — with the next questions focusing on whether the cognitive decline can continue for up to 10 years and how best to treat it.

Investigators Looking to a Better Future for Patients with Bladder Cancer 

Investigators Looking to a Better Future for Patients with Bladder Cancer 

Wilmot researchers are revealing new insights into what drives the disease and possible new treatment pathways. 

Lymphoma: Targeting treatment for special populations

Lymphoma: Targeting treatment for special populations

Patrick Reagan, M.D., is working with Wilmot's Geriatric Oncology team, to develop a targeted approach for treating older adults with diffuse large B-cell lymphoma.